Literature DB >> 8894274

Identification of an S100A1/S100B target protein: phosphoglucomutase.

A Landar1, G Caddell, J Chessher, D B Zimmer.   

Abstract

Phosphoglucomutase was identified as a potential intracellular S100 target protein because it interacted with two members of the S100 family of calcium-modulated proteins, S100A1 and S100B, in gel overlay experiments. These results were confirmed by affinity chromatography experiments demonstrating that S100A1 and S100B bound to phosphoglucomutase-Sepharose in a calcium-dependent manner. In the reverse experiment, phosphoglucomutase bound to S100A1 and S100B-Sepharose in a calcium-dependent manner. S100A1 inhibited phosphoglucomutase activity in a calcium-dependent manner. In contrast, S100B stimulated phosphoglucomutase activity in a calcium-dependent manner. Other calcium-binding proteins (calmodulin, troponin C, parvalbumin, and alpha-lactalbumin) had no effect on phosphoglucomutase. These results suggest that the effects of S100A1 and S100B are not nonspecific effects of low molecular weight, acidic proteins. This is the first report of an S100 target protein whose activity is antagonistically regulated by S100A1 and S100B, suggesting that cellular diversity in intracellular calcium signaling pathways may be due, at least in part, to the complement of S100 proteins expressed in different cell types.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8894274     DOI: 10.1016/s0143-4160(96)90033-0

Source DB:  PubMed          Journal:  Cell Calcium        ISSN: 0143-4160            Impact factor:   6.817


  9 in total

1.  Age-dependent expression of S100beta in the brain of mice.

Authors:  Prashant K Modi; M S Kanungo
Journal:  Cell Mol Neurobiol       Date:  2010-01-23       Impact factor: 5.046

Review 2.  Calcium-dependent and -independent interactions of the S100 protein family.

Authors:  Liliana Santamaria-Kisiel; Anne C Rintala-Dempsey; Gary S Shaw
Journal:  Biochem J       Date:  2006-06-01       Impact factor: 3.857

3.  Insulin Stimulates S100B Secretion and These Proteins Antagonistically Modulate Brain Glucose Metabolism.

Authors:  Krista Minéia Wartchow; Ana Carolina Tramontina; Daniela F de Souza; Regina Biasibetti; Larissa D Bobermin; Carlos-Alberto Gonçalves
Journal:  Neurochem Res       Date:  2016-02-15       Impact factor: 3.996

4.  S100B Serum Levels in Schizophrenia Are Presumably Related to Visceral Obesity and Insulin Resistance.

Authors:  Johann Steiner; Aye Mu Myint; Kolja Schiltz; Sabine Westphal; Hans-Gert Bernstein; Martin Walter; Matthias L Schroeter; Markus J Schwarz; Bernhard Bogerts
Journal:  Cardiovasc Psychiatry Neurol       Date:  2010-06-10

5.  The Calcium-Dependent Interaction of S100B with Its Protein Targets.

Authors:  Danna B Zimmer; David J Weber
Journal:  Cardiovasc Psychiatry Neurol       Date:  2010-08-17

6.  Solution structure of S100A1 bound to the CapZ peptide (TRTK12).

Authors:  Nathan T Wright; Brian R Cannon; Paul T Wilder; Michael T Morgan; Kristen M Varney; Danna B Zimmer; David J Weber
Journal:  J Mol Biol       Date:  2009-03-13       Impact factor: 5.469

7.  S100A1: Structure, Function, and Therapeutic Potential.

Authors:  Nathan T Wright; Brian R Cannon; Danna B Zimmer; David J Weber
Journal:  Curr Chem Biol       Date:  2009-05-01

8.  Adipocytes as an Important Source of Serum S100B and Possible Roles of This Protein in Adipose Tissue.

Authors:  Carlos Alberto Gonçalves; Marina Concli Leite; Maria Cristina Guerra
Journal:  Cardiovasc Psychiatry Neurol       Date:  2010-06-28

9.  The Impact of High Glucose or Insulin Exposure on S100B Protein Levels, Oxidative and Nitrosative Stress and DNA Damage in Neuron-Like Cells.

Authors:  Adriana Kubis-Kubiak; Benita Wiatrak; Agnieszka Piwowar
Journal:  Int J Mol Sci       Date:  2021-05-24       Impact factor: 5.923

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.